IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER
Recurrent Epithelial Cancer of Ovary
CanariaBio Inc.monoclonal_antibodyPhase 2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Recurrent Epithelial Cancer of Ovary cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Wake Forest University Health Sciences | Phase 2 | BB |
Niraparib CanariaBio Inc. | Phase 2 | CCC |
Trientine National Cheng-Kung University Hospital | Phase 1/2 | CCC |
Inno-206 National Cheng-Kung University Hospital | Phase 1/2 | CCC |
Avelumab University of Texas Southwestern Medical Center | Phase 2 | CCC |
Dordaviprone Ira Winer | Phase 2 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →